November 21, 2022

The breathtaking pace of development for COVID-19 vaccines showed what was possible with enough resources. Subsequent development of the vaccines is a reminder that viruses are a moving target that is ever-changing. Vaccines for COVID-19, malaria, the flu, and many other diseases must constantly adapt to these changes to protect recipients from disease. But how can researchers anticipate which participants in a clinical trial will gain immunity days after they get a dose of a vaccine?

Read more at the Drexel News Blog.